MIRM Mirum Pharmaceuticals, Inc.

NEUTRAL Impact: 2/10 Insider Cluster (2 insiders)
Horizon days Filed Jun 2, 2026 Processed 10d 9h ago
Insider cluster: 2 insiders, $644K total
Latest settled — T+1d
MIRM ▲ +0.71% at T+1d
NEUTRAL call ✓ call won +0.71% · α vs SPY +0.31% · entry $91.84 → $92.49
Next anchor: T+5d due 4d ago
Currently $99.35 · +8.18% from $91.84 entry
Entry anchored
Jun 2, 2026
via day open
T+1d
+0.71%
call +0.71% · α +0.31%
$92.49
settled 10d ago
T+5d
call — · α —
due 4d ago
T+20d
call — · α —
in 18d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Mirum Pharmaceuticals CEO Christopher Peetz and Director Saira Ramasastry sold a combined $644K in open-market sales on June 1, 2026, following a cluster of non-cash derivative exercises by multiple directors on May 29. The sales represent ~0.01% of MIRM's $5.9B market cap — trivial in proportion — and are likely liquidity-driven after option exercises, not a bearish signal. The stock has strong analyst support (95% bullish) and the cluster lacks material dollar weight.

Key Financial Metrics

Direction
selling
Total Value
$644.0K
Insiders
2

Actionable Insight

The sales are routine post-exercise liquidity events at trivial scale. No bearish read-through. Monitor for any material insider buying (which would be a stronger signal) or for upcoming earnings/catalyst news that could shift sentiment.

Key Facts

  • CEO Peetz sold 2,602 shares at $94.64 for $246K on June 1, 2026
  • Director Ramasastry sold 3,977 shares at $100 for $398K on June 1, 2026
  • Both sales followed non-cash derivative exercises on May 29 (directors) and June 1 (CEO)
  • Total open-market sales of $644K represent ~0.01% of MIRM's $5.9B market cap
  • Analyst consensus is 95% bullish (18 Buy, 1 Hold, 0 Sell)
  • No open-market purchases in the cluster

Financial Impact

Total insider sales of $644K — immaterial relative to $5.9B market cap

insider ownershipdilution

Risk Factors

  • Insider sales could accelerate if stock continues to appreciate, but no evidence of coordinated selling
  • No purchases in cluster — lack of bullish insider signal

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (19 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MIRM-1780444246058
10 reports for MIRM
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+5▲ +14.39%Apr 27, 2026
Filters
Rows
Reports for MIRM — sortable, filterable
Type Now
Jun 11, 2026
1d ago
Institutional Cluster
BULLISH ★ 6/10
$98.66 awaiting T+1awaiting T+1$99.35 (+0.69%)
Jun 10, 2026
3d ago
Insider Cluster
NEUTRAL ★ 3/10
$95.52 awaiting T+1awaiting T+1$99.35 (+4.00%)
Jun 2, 2026
10d ago
Insider Cluster
NEUTRAL ★ 2/10
$91.84 $92.49▲ +0.71%▲ +0.31%$99.35 (+8.18%)
Jun 1, 2026
11d ago
144
NEUTRAL ★ 3/10
$92.17 $91.84▼ −0.36%▲ +0.36%$99.35 (+7.78%)
Jun 1, 2026
11d ago
144
NEUTRAL ★ 2/10
$92.17 $91.84▼ −0.36%▲ +0.33%$99.35 (+7.78%)
May 18, 2026
25d ago
8-K
MIXED ★ 6/10
$95.65 $96.95▲ +1.36%▲ +0.32%$99.35 (+3.86%)
May 4, 2026
5w ago
8-K
BULLISH ★ 6/10
$105.79 $105.81▲ +0.02%▼ −0.78%$99.35 (−6.09%)
Apr 27, 2026
6w ago
8-K
BULLISH ★ 8/10
$92.48 $94.00▲ +1.64%▲ +2.13%$99.35 (+7.42%)
Apr 15, 2026
8w ago
144
NEUTRAL ★ 2/10
$95.86 $97.95▲ +2.18%▲ +0.97%$99.35 (+3.64%)
Feb 25, 2026
15w ago
8-K
BULLISH ★ 8/10
$108.62 $92.19▼ −15.13%▼ −14.58%$99.35 (−8.54%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (52h 21m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access